| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06898970 | Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for… | Angiosarcoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT06177171 | Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated… | BRCA1 Mutation | Recruiting |